HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Studies Trace Element Content In Cosmetics; Guidance To Come?

This article was originally published in The Rose Sheet

Executive Summary

In a study recently published in the Journal of Cosmetic Science, FDA assessed levels of seven trace contaminants in 150 cosmetic products on the market. The agency says the survey will help it to “make appropriate decisions regarding elemental contaminants in cosmetics.”

You may also be interested in...



FDA Will Respond To Lipstick Lead-Limit Petition In March

According to President Obama’s fiscal 2016 budget request, FDA expects to meet the March 2015 due date imposed by Congress for responding to a citizen petition to set a maximum limit on lead in cosmetic products.

ICCR Will Have Growing Role In Setting Global Policy – Industry Groups

Following the International Cooperation on Cosmetics Regulation’s eighth meeting in Ottawa, representatives from trade groups PCPC and CCTFA spoke with “The Rose Sheet” about ICCR’s progress to date and its growing influence on regulation within core member jurisdictions, as well as with other stakeholders around the world.

Congressional Appropriators Urge FDA Action On Cosmetic Lead Limits

House and Senate committee reports on proposed FDA appropriations for fiscal 2015 direct the agency to respond to a nearly three-year-old petition requesting an agency-sanctioned limit on trace lead in lipstick and other cosmetics. Appropriators set a March 15, 2015 deadline for FDA’s response.

Related Content

UsernamePublicRestriction

Register

RS019163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel